Acacia acquires Biotech Stakes: an insight into the companies and patents behind the deal
Acacia acquires Biotech Stakes
On 5th June, a portfolio of shares in 19 life science companies was agreed to be sold by Neil Woodford’s LF Equity Income Fund to Acacia Research for up to £224 million. To date, nine assets have been transferred to Acacia Research, many of these have already been sold on.
Acacia acquires Biotech Stakes looks at the patent assets and companies behind the deal and delves into:
- Which companies are involved in this transaction?
- What can this tell us about Acacia Research’s overall strategy?
- What information has been kept in the dark?
Find out in our latest article which companies and patents are involved in this deal as well as what this says about Acacia’s strategy.